Glutathione is a key player in this defense system, protecting cells from damage that can lead to illness and disease
Practical Considerations Dose Titration Both compounds require careful dose escalation
GLP-1 drugs are not approved MS treatments, but early research suggests that they may affect inflammation and nerve health in ways that could be relevant to MS
By mimicking GLP-1, these drugs slow stomach emptying, increase feelings of fullness, and reduce cravings, making them highly effective for both diabetes management and weight loss
The adverse events associated with GLP-1RA are predominantly GI, particularly nausea, vomiting, and diarrhea, and occur in 1050% of patients in clinical trials (Table 2) (32)